DK0763100T3 - Fremgangsmåde til rensning af Clostridium difficile-texin og fremstilling af monospecifkke antistoffer - Google Patents
Fremgangsmåde til rensning af Clostridium difficile-texin og fremstilling af monospecifkke antistofferInfo
- Publication number
- DK0763100T3 DK0763100T3 DK95942617T DK95942617T DK0763100T3 DK 0763100 T3 DK0763100 T3 DK 0763100T3 DK 95942617 T DK95942617 T DK 95942617T DK 95942617 T DK95942617 T DK 95942617T DK 0763100 T3 DK0763100 T3 DK 0763100T3
- Authority
- DK
- Denmark
- Prior art keywords
- texin
- purification
- preparation
- clostridium difficile
- monospecific antibodies
- Prior art date
Links
- 241000193403 Clostridium Species 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/414,640 US5610023A (en) | 1995-03-31 | 1995-03-31 | Method of purification of clostridium difficile toxin A and production of mono-specific antibodies |
| PCT/US1995/016150 WO1996030494A1 (en) | 1995-03-31 | 1995-12-08 | Method of purification of clostridium difficile toxin a and production of mono-specific antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0763100T3 true DK0763100T3 (da) | 2008-09-15 |
Family
ID=23642303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95942617T DK0763100T3 (da) | 1995-03-31 | 1995-12-08 | Fremgangsmåde til rensning af Clostridium difficile-texin og fremstilling af monospecifkke antistoffer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5610023A (da) |
| EP (1) | EP0763100B1 (da) |
| JP (1) | JP2001505525A (da) |
| AU (1) | AU4378296A (da) |
| CA (1) | CA2191774A1 (da) |
| DE (1) | DE69535754D1 (da) |
| DK (1) | DK0763100T3 (da) |
| WO (1) | WO1996030494A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179611B2 (en) | 1997-02-10 | 2007-02-20 | Bd Lee Laboratories | Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A |
| US5965375A (en) * | 1997-04-04 | 1999-10-12 | Biosite Diagnostics | Diagnostic tests and kits for Clostridium difficile |
| AU746859B2 (en) * | 1997-06-20 | 2002-05-02 | Imperial College Of Science, Technology And Medicine | Immonogenic fragments of toxin a of clostridium difficile |
| US6290946B1 (en) * | 1999-05-13 | 2001-09-18 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders and antibacterial agents |
| US6270755B1 (en) | 1999-05-13 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders |
| CA2314494A1 (en) | 2000-05-02 | 2001-11-02 | Geltex Pharmaceuticals, Inc. | Anionic polymers as species specific antibacterial agents |
| CA2492211A1 (en) * | 2002-07-22 | 2004-01-29 | Genzyme Corporation | Poly(potassium and sodium styrene sulfonate), its manufacture and its uses |
| US20060078534A1 (en) * | 2004-10-13 | 2006-04-13 | Dominique Charmot | Toxin binding compositions |
| JP2008515996A (ja) * | 2004-10-13 | 2008-05-15 | イリプサ, インコーポレイテッド | 毒素結合性オリゴ糖および重合体粒子を含有する医薬組成物 |
| CA2714720A1 (en) | 2008-02-28 | 2009-09-03 | 3M Innovative Properties Company | Antibodies to clostridium difficile spores and uses thereof |
| MX391236B (es) | 2011-04-22 | 2025-03-21 | Wyeth Llc | Composiciones relacionadas con una toxina de clostridium difficile mutante y sus metodos. |
| BR122016023101B1 (pt) | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
| US20160045586A1 (en) * | 2013-03-15 | 2016-02-18 | Sanofi Pasteur, Inc. | Toxoid, Compositions and Related Methods |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652636A1 (de) * | 1976-11-19 | 1978-05-24 | Hans Uwe Dr Rer Nat Wolf | Verfahren zur stabilisierung von proteinen und verwandten verbindungen waehrend ihrer reinigung, isolierung und lagerung |
| FI63596C (fi) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser |
| US4937201A (en) * | 1982-06-10 | 1990-06-26 | Mitsubishi Kasei Corporation | Latex reagent for detection of the toxin of clostridium difficile |
| US4530833A (en) * | 1982-09-13 | 1985-07-23 | Wilkins Tracy D | Toxins and antibodies of C. difficile |
| US4533630A (en) * | 1982-09-13 | 1985-08-06 | Wilkins Tracy D | Toxins and antibodies of C. difficile |
| US4879218A (en) * | 1982-09-13 | 1989-11-07 | Virginia Tech Intellectual Properties, Inc. | Antibody for C.difficile |
| US4689299A (en) * | 1982-09-30 | 1987-08-25 | University Of Rochester | Human monoclonal antibodies against bacterial toxins |
| EP0154064A1 (en) * | 1984-03-02 | 1985-09-11 | Tracy Dale Wilkins | Toxins and antibodies of C. difficile |
| EP0153519B1 (en) * | 1984-03-02 | 1988-06-01 | Tracy Dale Wilkins | Toxins and antibodies of c. difficile |
| US4959457A (en) * | 1984-05-31 | 1990-09-25 | Genentech, Inc. | Anti-lymphotoxin |
| US4863852A (en) * | 1985-07-03 | 1989-09-05 | Virginia Tech Intellectual Properties, Inc. | Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors |
| US5071759A (en) * | 1986-05-30 | 1991-12-10 | The United States Of America As Represented By The Secretary Of The Army | Hybridoma cell lines and monoclonal antibodies to clostridum difficile toxins A and B |
| DK255887D0 (da) * | 1987-05-20 | 1987-05-20 | Claus Koch | Immunoassay |
| US5098826A (en) * | 1990-03-09 | 1992-03-24 | Virginia Tech Intellectual Properties, Inc. | Detection, isolation and purification of Clostridium difficile toxin A with toxin receptors |
| US5266315A (en) * | 1990-05-07 | 1993-11-30 | Kabushiki Kaisha Miyarisan Seibutsu Igaku Kenkyusho | Composite for Clostridium difficile diarrhea and pseudomembranous colitis |
| US5231003A (en) * | 1990-05-11 | 1993-07-27 | Cambridge Bioscience Corporation | Monoclonal antibodies specific for toxin b of clostridium difficile |
| US5545721A (en) * | 1992-12-21 | 1996-08-13 | Ophidian Pharmaceuticals, Inc. | Conjugates for the prevention and treatment of sepsis |
-
1995
- 1995-03-31 US US08/414,640 patent/US5610023A/en not_active Expired - Lifetime
- 1995-12-08 DE DE69535754T patent/DE69535754D1/de not_active Expired - Fee Related
- 1995-12-08 EP EP95942617A patent/EP0763100B1/en not_active Expired - Lifetime
- 1995-12-08 WO PCT/US1995/016150 patent/WO1996030494A1/en not_active Ceased
- 1995-12-08 AU AU43782/96A patent/AU4378296A/en not_active Abandoned
- 1995-12-08 DK DK95942617T patent/DK0763100T3/da active
- 1995-12-08 CA CA002191774A patent/CA2191774A1/en not_active Abandoned
- 1995-12-08 JP JP52932096A patent/JP2001505525A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0763100A1 (en) | 1997-03-19 |
| CA2191774A1 (en) | 1996-10-03 |
| EP0763100A4 (en) | 2001-12-05 |
| EP0763100B1 (en) | 2008-05-14 |
| WO1996030494A1 (en) | 1996-10-03 |
| DE69535754D1 (de) | 2008-06-26 |
| JP2001505525A (ja) | 2001-04-24 |
| US5610023A (en) | 1997-03-11 |
| AU4378296A (en) | 1996-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0833807T3 (da) | Katalysator og fremgangsmåde til fremstilling af carbonhydrider | |
| DK0770615T3 (da) | Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner | |
| DK0807086T3 (da) | Fremgangsmåde til fremstilling af hydrotalciter | |
| DK0754756T3 (da) | Fremgangsmåde til fremstilling af L-lysin | |
| DK0815074T3 (da) | O-carbamoyl-(D)-phenylalaniforbindelser og fremgangsmåde til fremstilling af disse | |
| DK0782825T3 (da) | Modificeret valleprotein og proces til fremstilling af dette | |
| DK0811682T3 (da) | Fremgangsmåde til fremstilling af L-lysin | |
| DK0857784T3 (da) | Fremgangsmåde til fremstilling af L-lysin | |
| DK0812357T3 (da) | Fremgangsmåde til fremstilling af heteromultimere polypeptider | |
| DK0850004T3 (da) | Tandbørste og fremgangsmåde til fremstilling af en sådan | |
| NO981826D0 (no) | Filterelement og fremgangsmÕte for fremstilling | |
| FI970301L (fi) | Spesifisen immunoglobuliinin määrittäminen käyttäen useampaa antigeenia | |
| DK0996728T3 (da) | Forbedrede anti-IgE antistoffer og fremgangsmåde til forbedring af antistoffer | |
| DK0911416T3 (da) | Fremgangsmåde til fremstilling af protein | |
| DK0613004T3 (da) | Præparat til bestemmelse af endotoxin og fremgangsmåde til bestemmelse af endotoxin under anvendelse af dette | |
| DK0763100T3 (da) | Fremgangsmåde til rensning af Clostridium difficile-texin og fremstilling af monospecifkke antistoffer | |
| DK0839153T3 (da) | Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider | |
| DK0789767T3 (da) | Fremgangsmåde til fremstilling af oprensede papilomavirusproteiner | |
| DK0831098T3 (da) | Mellemprodukter og fremgangsmåde til fremstilling af olanzapin | |
| DK475389D0 (da) | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet | |
| DK0839138T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler | |
| DK0805797T3 (da) | Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer | |
| DK0709455T3 (da) | Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an | |
| DK0888168T3 (da) | Fremgangsmåde til rensning af procesgasser | |
| DK0736605T3 (da) | Fremgangsmåde til fremstilling af proteiner |